お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
987792

世界の止血剤・組織シーラント市場:2021年~2025年

Global Hemostats and Tissue Sealants Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.99円
世界の止血剤・組織シーラント市場:2021年~2025年
出版日: 2021年02月10日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の止血剤・組織シーラントの市場規模は、2021年から2025年の間に15億米ドル成長し、予測期間中は10%のCAGRで成長する見込みです。

市場は、手術での止血剤と組織シーラントの使用、新製品の発売によって推進されています。

当レポートでは世界の止血剤・組織シーラント市場を調査し、全体的な分析、市場規模と予測、動向、成長要因、および課題、ならびに約25のベンダーをカバーするベンダー分析を提供します。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2020年の市場規模
  • 市場の見通し:2020年から2025年の予測

ファイブフォース分析

市場セグメンテーション:製品別

  • 市場セグメント
  • 製品別比較
  • 止血剤:市場規模と予測(2020年~2025年)
  • 組織シーラント・接着剤:市場規模と予測(2020年~2025年)
  • フィブリンシーラント:市場規模と予測(2020年~2025年)
  • COVID-19パンデミックの影響と製品別回復
  • 製品別の市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2020年~2025年)
  • 欧州:市場規模と予測(2020年~2025年)
  • アジア:市場規模と予測(2020年~2025年)
  • その他の地域:市場規模と予測(2020年~2025年)
  • 主要国
  • 地域別の市場機会
  • 市場の推進力
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • CryoLife Inc.
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

付録

目次
Product Code: IRTNTR40802

Technavio has been monitoring the hemostats and tissue sealants market and it is poised to grow by $ 1.50 bn during 2021-2025 progressing at a CAGR of 10% during the forecast period. Our report on hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the use of hemostats and tissue sealants in surgeries and technological advances and new product launches. In addition, use of hemostats and tissue sealants in surgeries is anticipated to boost the growth of the market as well.

The hemostats and tissue sealants market analysis includes product segment and geographical landscapes.

Technavio's hemostats and tissue sealants market is segmented as below:

By Product

  • Hemostats
  • Tissue sealants and adhesives
  • Fibrin sealants

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing prevalence of chronic diseases and related risk factors as one of the prime reasons driving the hemostats and tissue sealants market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hemostats and tissue sealants market covers the following areas:

  • Hemostats and tissue sealants market sizing
  • Hemostats and tissue sealants market forecast
  • Hemostats and tissue sealants market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hemostats and tissue sealants market vendors that include Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc., and Teleflex Inc.. Also, the hemostats and tissue sealants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Hemostats - Market size and forecast 2020-2025
  • Tissue sealants and adhesives - Market size and forecast 2020-2025
  • Fibrin sealants - Market size and forecast 2020-2025
  • Impact of COVID-19 pandemic and recovery by product
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor Landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • CryoLife Inc.
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Hemostats - Market size and forecast 2020-2025 ($ million)
  • 24: Hemostats - Year-over-year growth 2020-2025 (%)
  • 25: Tissue sealants and adhesives - Market size and forecast 2020-2025 ($ million)
  • 26: Tissue sealants and adhesives - Year-over-year growth 2020-2025 (%)
  • 27: Fibrin sealants - Market size and forecast 2020-2025 ($ million)
  • 28: Fibrin sealants - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by Product
  • 30: Customer landscape
  • 31: Market share by geography 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Advanced Medical Solutions Group Plc - Overview
  • 50: Advanced Medical Solutions Group Plc - Business segments
  • 51: Advanced Medical Solutions Group Plc - Key offerings
  • 52: Advanced Medical Solutions Group Plc - Key customers
  • 53: Advanced Medical Solutions Group Plc - Segment focus
  • 54: B. Braun Melsungen AG - Overview
  • 55: B. Braun Melsungen AG - Business segments
  • 56: B. Braun Melsungen AG - Key offerings
  • 57: B. Braun Melsungen AG - Key customers
  • 58: B. Braun Melsungen AG - Segment focus
  • 59: Baxter International Inc. - Overview
  • 60: Baxter International Inc. - Business segments
  • 61: Baxter International Inc. - Key offerings
  • 62: Baxter International Inc. - Key customers
  • 63: Baxter International Inc. - Segment focus
  • 64: Becton, Dickinson and Co. - Overview
  • 65: Becton, Dickinson and Co. - Business segments
  • 66: Becton, Dickinson and Co. - Key offerings
  • 67: Becton, Dickinson and Co. - Key customers
  • 68: Becton, Dickinson and Co. - Segment focus
  • 69: CryoLife Inc. - Overview
  • 70: CryoLife Inc. - Business segments
  • 71: CryoLife Inc. - Key offerings
  • 72: CryoLife Inc. - Key customers
  • 73: CryoLife Inc. - Segment focus
  • 74: Integra LifeSciences Corp. - Overview
  • 75: Integra LifeSciences Corp. - Business segments
  • 76: Integra LifeSciences Corp. - Key offerings
  • 77: Integra LifeSciences Corp. - Key customers
  • 78: Integra LifeSciences Corp. - Segment focus
  • 79: Johnson & Johnson - Overview
  • 80: Johnson & Johnson - Business segments
  • 81: Johnson & Johnson - Key offerings
  • 82: Johnson & Johnson - Key customers
  • 83: Johnson & Johnson - Segment focus
  • 84: Medtronic Plc - Overview
  • 85: Medtronic Plc - Business segments
  • 86: Medtronic Plc - Key offerings
  • 87: Medtronic Plc - Key customers
  • 88: Medtronic Plc - Segment focus
  • 89: Pfizer Inc. - Overview
  • 90: Pfizer Inc. - Business segments
  • 91: Pfizer Inc. - Key offerings
  • 92: Pfizer Inc. - Key customers
  • 93: Pfizer Inc. - Segment focus
  • 94: Teleflex Inc. - Overview
  • 95: Teleflex Inc. - Business segments
  • 96: Teleflex Inc. - Key offerings
  • 97: Teleflex Inc. - Key customers
  • 98: Teleflex Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.